Wall Street Researcher

Pressure BioSciences   - PBIO OTCQB - Trading Alert

Target Price Reached - New Target Set $0.40

These shares have corrected and have formed a strong base at the $0.16 level . This stock is driven by a superior management team and a proven product.

We anticipate a strong upturn and place a $0.38 short term target price on these shares an easy double.

A Huge Short Position Adds Upside Volatility To These Shares - Read This Article On Shorts In PBIO

Top Percentage Gainer

Todays Trading Alerts - News Alerts

Pressure BioSciences, Inc. Discusses Research Market, Goals and Milestones for First Half of 2017 in New SNNLive Video Interview with StockNewsNow.com - WATCH VIDEO BELOW

LOS ANGELES, Feb. 8, 2017 /PRNewswire/ -- StockNewsNow.com, The Official MicroCap News Sourceā„¢, today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website.The video interview was recorded on Thursday, December 8th, 2016 at the LD Micro "Main Event" 2016 in Bel Air, CA.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. ("PBI") (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. Cancer Moonshot

PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and forensic applications. Barrons Article On Medical Device Companies

For more information, visit: www.PressureBioSciences.com

About StockNewsNow.com

StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.

Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for - all here on StockNewsNow.com.

SOURCE Wall Street Researecher









 










 

 

 

 

 

 

 

 

 

 

 

 

X